The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
36
Synthesis and antimycobacterial activity of capuramycin analogues. Part 2: acylated derivatives of capuramycin-related compounds.EBI
Sankyo
2
Identification of novel inhibitors of phospho-MurNAc-pentapeptide translocase MraY from library screening: Isoquinoline alkaloid michellamine B and xanthene dye phloxine B.EBI
University of Warwick
8
Synthesis of pacidamycin analogues via an Ugi-multicomponent reaction.EBI
Shionogi
20
3-Arylpiperidines as potentiators of existing antibacterial agents.EBI
Pharmacia
4
Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.EBI
Hokkaido University
5
Synthesis and Biological Evaluation of Muraymycin Analogues Active against Anti-Drug-Resistant Bacteria.EBI
TBA
13
Synthesis and biological evaluation of a diazepanone-based library of liposidomycins analogs as MraY inhibitors.EBI
University of Paris
5
Bacterial transferase MraY inhibitors: synthesis and biological evaluation.EBI
University of Paris
12
Function-oriented synthesis of simplified caprazamycins: discovery of oxazolidine-containing uridine derivatives as antibacterial agents against drug-resistant bacteria.EBI
Hokkaido University
21
Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold.EBI
Tokyo University of Agriculture and Technology
35
Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?EBI
Cardiff University
6
Inhibition of phospho-MurNAc-pentapeptide translocase (MraY) by nucleoside natural product antibiotics, bacteriophage ϕX174 lysis protein E, and cationic antibacterial peptides.EBI
University of Warwick
5
Synthesis of capuramycin and its analogues via a Ferrier-type I reaction and their biological evaluation.EBI
Hokkaido University
6
Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5'-O-aminoribosyluridine as MraY inhibitors.EBI
Hokkaido University
71
Synthesis and antimycobacterial activity of capuramycin analogues. Part 1: substitution of the azepan-2-one moiety of capuramycin.EBI
Sankyo
3
Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY.EBI
Duke University
14
Synthesis of analogues of the O-beta-D-ribofuranosyl nucleoside moiety of liposidomycins. Part 1: contribution of the amino group and the uracil moiety upon the inhibition of MraY.EBI
Aventis Pharma
4
Structural requirement of tunicamycin V for MraY inhibition.EBI
Hokkaido University
49
Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.EBI
Griffith University
1
Lipophosphonoxins: new modular molecular structures with significant antibacterial properties.EBI
Academy of Sciences of The Czech Republic V.V.I.
5
Antibacterial Muraymycins from Mutant Strains of Streptomyces sp. NRRL 30471.EBI
Nanjing University of Chinese Medicine
1074
N-substituted indole derivatives as PGE2 receptor modulatorsBDB
Idorsia Pharmaceuticals